Tuberous Sclerosis: Clinical Trials

3 trials for Tuberous Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting. 3 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Active not recruiting 3
Phase 12Active not recruiting 2

Follow Tuberous Sclerosis: new trials by email Literature Review of Tuberous Sclerosis trials Research Report on Tuberous Sclerosis

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II
Radiprodil - Tuberous Sclerosis Complex, Focal Cortical Dysplasia
Phase 1 / Phase 2Active not recruitingGRIN Therapeutics, Inc.302024-07-102026-04-01
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Sirolimus, Placebo - Tuberous Sclerosis Complex, Epilepsy
Phase 2Active not recruitingDarcy Krueger642021-10-132026-10-29
Feasibility of [11C]Acetate-PET in LAM and TSC
[11C]acetate - Lymphangioleiomyomatosis, Tuberous Sclerosis Complex
Phase 1 / Phase 2Active not recruitingBrigham and Women's Hospital72021-08-302026-01-21

Narrower conditions

Epilepsy (1)  ·  Focal Cortical Dysplasia (1)  ·  Lymphangioleiomyomatosis (1)

Broader conditions

Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Genetic Diseases, Inborn (3)  ·  Hamartoma (3)  ·  Heredodegenerative Disorders, Nervous System (3)  ·  Malformations of Cortical Development (3)  ·  Malformations of Cortical Development, Group I (3)  ·  Neoplasms (3)  ·  Neoplasms, Multiple Primary (3)  ·  Neoplastic Syndromes, Hereditary (3)  ·  Nervous System Diseases (3)  ·  Nervous System Malformations (3)  ·  Neurocutaneous Syndromes (3)  ·  Neurodegenerative Diseases (3)  ·  Brain Diseases (1)

Interventions

Sirolimus (1)  ·  carbon-11 acetate (1)  ·  radiprodil (1)

Sponsors

Brigham and Women's Hospital (1)  ·  Darcy Krueger (1)  ·  GRIN Therapeutics, Inc. (1)

Countries

United States (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Carmen P Priolo, MD PhD (1)  ·  Darcy A Krueger, MD, PhD (1)  ·  Martina Bebin, MD, MPA (1)

NIH funding

2023 (1)